Princeton University's Chang Lab has developed a sensing probe that can detect copper in human cells at a high level of sensitivity.
Copper is a nutrient metal that has essential as well as detrimental impacts on human cells.
The Chang Lab focuses on understanding the role of copper in cancerous growth, particularly in lung cancer.
The lab has collaborated with researchers from notable institutions to investigate copper-dependent signaling that might affect cancer cell proliferation.
Their findings suggest copper chelation could be used to disrupt the growth of cancer cells that rely excessively on copper.
The Chang Lab's research provides a targeted approach to understanding how metal nutrients like copper can be manipulated for therapeutic purposes.
Lung cancer cells that possess high levels of NRF2 exhibit vulnerabilities when subjected to copper deprivation.
This research expands the understanding of cancer biology by incorporating nutrition-related factors and has the potential to redefine therapeutic paradigms.
Future research must validate the findings and refine the chelation strategies for therapeutic applications.
The overarching goal is to enable targeted therapies that could shift approaches to cancer treatment.